Regulatory & Safety
Internet Live Events
Mergers and acquisitions
APIs (active pharmaceutical ingredients)
Excipients, raw materials and intermediates
Packaging machinery & supplies
Tabletting, coating & ancillary equipment
Videos & Audio
Shows & Conferences
CPhI Worldwide Paris 2014
AAPS 2014 San Diego
TechnoPharm / POWTECH 2014 Nuremberg, Germany
AAPS 2013 in San Antonio
CPhI 2013 in Frankfurt
Interphex 2013 in New York
AAPS 2012 in Chicago
CPhI 2012 in Madrid
Achema 2012 in Frankfurt
Interphex 2012 in New York
Interphex 2011 in New York
AAPS 2010 in New Orleans
Once president of group research at Roche Holdings, Knowles now joins the board at Adaptimmune as a non-executive director.
He joins the firm's current chief operating officer Helen Tayton-Martin, who will become executive director.
Thomas Christély, CEO at Silence Therapeutics
Gary Foulks, member InSite Vision's new scientific advisory board
Kamran Hosseini leader of InSite Vision's new scientific advisory board
Michael Lemp, member of InSite Vison's new scientific advisory board
Brian Levy, helping to lead InSite Vision's new scientific advisory board
Richard Lindstrom, member of InSite Vision's new scientific advisory board
Kelly Nichols, member of InSite Vision's new scientific advisory board
Dennis Kim, chief medical officer at Zafgen
Helen Tayton-Martin, executive director at Adaptimmune
Jonathan Knowles, non-executive board member at Adaptimmune
And microbiology awards to research scientists and Médecins Sans Frontières.
Access all events listing
Our events, Shows & Conferences...
Subscribe to our FREE newsletterSUBSCRIBE
Contract Research, Manufacturing & Clinical Trials
Biopharmaceutical Development & Manufacturing
About us | Site map |
© William Reed Business Media SAS 2015, All rights reserved.